CIK 0001665988 · Accelerated filer<br>Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810980861
- Phone
- (919) 474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 8-K Event Results of operations
- 8-K Event Material agreement · Regulation FD disclosure
- NT 10-Q Other NT 10-Q
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale Fmr. Chief Commercial Officer sold 142 shares at an average $8.81 ($1,251)
- 4 Planned sale SVP & Chief Compliance Officer sold 131 shares at an average $7.69 ($1,007)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K/A Event Executive or director change
- 3 Insider Initial Statement of Ownership
- 4 Planned sale SVP & Chief Compliance Officer sold 117 shares at $1.07 ($125)
- 8-K Event Executive or director change
- 10-K Report Annual Report
Page 13 of 24 · 463 filings